FAQs ABOUT OROFER FCM
How does OROFER FCM work?
OROFER FCM contains iron (III) hydroxide complexed with a carbohydrate polymer called carboxymaltose, which is capable of releasing iron. The iron released from the complex helps in the synthesis of haemoglobin and increases red blood cell count. As a result, it treats iron deficiency anaemia.
Is OROFER FCM safe to use in patients with kidney problems?
OROFER FCM should be used with caution in patients with chronic kidney disease who are dependent of haemodialysis treatment. Consult your doctor before receiving OROFER FCM.
Who should avoid receiving OROFER FCM?
OROFER FCM is not recommended for use in patients with evidence of iron overload or disturbances in the utilisation of iron, anaemia not attributed to iron deficiency (microcytic anaemia) and with known allergic to ferric carboxymaltose or serious allergic to other parenteral iron products.
Is OROFER FCM safe to use in elderly patients?
OROFER FCM should be used with caution in elderly patients (aged 65 years or above). Your doctor may monitor you carefully during administration and certain time after administration of OROFER FCM. Consult your doctor before receiving OROFER FCM.
Can OROFER FCM be used during pregnancy?
OROFER FCM should be used with caution in pregnant women only if clearly advised by your doctor. Inform your doctor if you are pregnant, think you may be pregnant, or planning to have a baby. Consult your doctor before receiving OROFER FCM.